Authors:
Grieve, R
Hutton, J
Bhalla, A
Rastenyte, D
Ryglewicz, D
Sarti, C
Lamassa, M
Giroud, M
Dundas, R
Wolfe, CDA
Citation: R. Grieve et al., A comparison of the costs and survival of hospital-admitted stroke patients across Europe, STROKE, 32(7), 2001, pp. 1684-1691
Authors:
Kelly, S
Harris, KM
Berry, E
Hutton, J
Roderick, P
Cullingworth, J
Gathercole, L
Smith, MA
Citation: S. Kelly et al., A systematic review of the staging performance of endoscopic ultrasound ingastro-oesophageal carcinoma, GUT, 49(4), 2001, pp. 534-539
Authors:
Diez, J
Park, Y
Zeller, M
Brown, D
Garza, D
Ricordi, C
Hutton, J
Eisenbarth, GS
Pugliese, A
Citation: J. Diez et al., Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen, DIABETES, 50(4), 2001, pp. 895-900
Authors:
Berto, P
Munro, V
Gaddi, A
Negrini, C
Hutton, J
Mast, O
Citation: P. Berto et al., Cost-effectiveness analysis for statin therapies in the primary preventionof coronary heart disease in Italy, CLIN DRUG I, 20(2), 2000, pp. 109-121
Citation: M. Chambers et al., Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole (vol 16, pg 577, 1999), PHARMACOECO, 17(1), 2000, pp. 69-69
Citation: J. Hutton, Assessing the cost-effectiveness of imaging technology: recent results, problems and progress in the UK, EUR RADIOL, 10, 2000, pp. S427-S429
Citation: R. Grieve et al., A comparison of the cost-effectiveness of stroke care provided in London and Copenhagen, INT J TE A, 16(2), 2000, pp. 684-695
Citation: M. Chambers et al., Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK - Aspirin, dipyridamole and aspirin-dipyridamole, PHARMACOECO, 16(5), 1999, pp. 577-593
Citation: J. Hutton et al., Assessing the potential cost effectiveness of pneumococcal vaccines in theUS - Methodological issues and current evidence, DRUG AGING, 15, 1999, pp. 31-36
Authors:
Buyse, M
George, SL
Evans, S
Geller, NL
Ranstam, J
Scherrer, B
Lesaffre, E
Murray, G
Edler, L
Hutton, J
Colton, T
Lachenbruch, P
Verma, BL
Citation: M. Buyse et al., The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials, STAT MED, 18(24), 1999, pp. 3435-3451
Citation: J. Hutton, The economics of immunosuppression in renal transplantation: A review of recent literature, TRANSPLAN P, 31(1-2), 1999, pp. 1328-1332
Citation: Re. Brown et J. Hutton, Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients, ANTI-CANC D, 9(10), 1998, pp. 899-907